GS 504: Began an open-label trial in the U.S. and U.K.

Gilead Sciences Inc. (GILD), Foster City, Calif. Product: GS 504, nucleotide analog that inhibits viral replication Indication: Relapsing cytomegalovirus infection of the retina in AIDS Status: Began...